Oragenics, Inc. (OGEN)
0.5399
+0.02
(+3.81%)
USD |
NYAM |
Aug 26, 14:07
Oragenics Total Liabilities (Quarterly) : 1.822M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.822M |
| March 31, 2026 | 1.308M |
| December 31, 2025 | 1.786M |
| September 30, 2025 | 2.874M |
| June 30, 2025 | 4.267M |
| March 31, 2025 | 3.731M |
| December 31, 2024 | 1.684M |
| September 30, 2024 | 2.126M |
| June 30, 2024 | 1.383M |
| March 31, 2024 | 0.9087M |
| December 31, 2023 | 1.798M |
| September 30, 2023 | 1.402M |
| June 30, 2023 | 1.207M |
| March 31, 2023 | 1.885M |
| December 31, 2022 | 1.749M |
| September 30, 2022 | 1.778M |
| June 30, 2022 | 1.678M |
| March 31, 2022 | 1.663M |
| December 31, 2021 | 1.745M |
| September 30, 2021 | 2.545M |
| June 30, 2021 | 2.514M |
| March 31, 2021 | 1.315M |
| December 31, 2020 | 1.836M |
| September 30, 2020 | 1.642M |
| June 30, 2020 | 1.944M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.653M |
| December 31, 2019 | 2.521M |
| September 30, 2019 | 2.833M |
| June 30, 2019 | 2.510M |
| March 31, 2019 | 2.185M |
| December 31, 2018 | 1.168M |
| September 30, 2018 | 1.557M |
| June 30, 2018 | 1.558M |
| March 31, 2018 | 1.179M |
| December 31, 2017 | 0.8985M |
| September 30, 2017 | 4.122M |
| June 30, 2017 | 4.072M |
| March 31, 2017 | 1.165M |
| December 31, 2016 | 1.343M |
| September 30, 2016 | 0.9093M |
| June 30, 2016 | 0.8978M |
| March 31, 2016 | 1.083M |
| December 31, 2015 | 1.047M |
| September 30, 2015 | 5.887M |
| June 30, 2015 | 5.601M |
| March 31, 2015 | 0.606M |
| December 31, 2014 | 0.7963M |
| September 30, 2014 | 0.7395M |
| June 30, 2014 | 0.7779M |
| March 31, 2014 | 0.9381M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.492M |
| Shareholders Equity (Quarterly) | 3.671M |
| Current Ratio | 3.015 |
| Net Debt Paydown Yield | 19.50% |